pipeline-prospector-insert
X

Overview of Prednisone

Client Email Product
Tox21_300196
  • Synopsis

  • Chemistry

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)

0

API Market Place

INTERMEDIATES

0

DOSSIERs
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

Dossiers Market Place

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

MEDIA

Blog

News

REFERENCE STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

0

SERVICES

0

  • FDA
  • EDQM
Applications: Advantose® FS95 spray-dried fructose is coprocessed with a small quantity of starch, which results in a highly compressible excipient for pharmaceutical, nutraceutical, and chewable vitamin applications.
Ingredient(s): Fructose
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
  • WHO-GMP
Applications: Orally Disintegrating Tablets/Sachets, Dispersible Tablets/ Sachets, Chewable Tablets, Sublingual Tablets
Ingredient(s): Crospovidone
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to Japanese Pharmaceutical Excipients. All components meet USP-NF, JP, and EP.
Technical Specifications: Not Available
  • FDA
  • EDQM
Applications: Dry binder & fast disintegrant, suitable for small tablets and ODTs, providing pleasant mouthfeel due to finer particles.
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type B
Technical Specifications: Not Available
    Applications: HiCel CE15 offers a superior mouth feel with less chalkiness and gritness in chewable tablets.
    Route of Administration (Grade): Oral
    Pharmacopoeia Reference: Not Available
    Technical Specifications: Not Available
    • FDA
    • EDQM
    Applications: Ready-to-use ODT solution with superior mouthfeel.
    Ingredient(s): Polyvinyl Acetate
    Route of Administration (Grade): Not Available
    Pharmacopoeia Reference: Ph. Eur., USP, JP: 90 % mannitol, 5 % crospovidone, 5 % polyvinyl acetate
    Technical Specifications: Not Available
    • FDA
    • EDQM
    Applications: Balance of strong disintegration and optimal surface homogeneity.
    Route of Administration (Grade): Not Available
    Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type A
    Technical Specifications: Not Available
    left grey arrow
    right gray arrow
    • TABLET, DELAYED RELEASE;ORAL - 1MG
    • TABLET, DELAYED RELEASE;ORAL - 2MG
    • TABLET, DELAYED RELEASE;ORAL - 5MG
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Advertise With Us

    Advertise With Us